Thomas Story & Son LLC Lowers Stake in Procter & Gamble Co (NYSE:PG)

Share on StockTwits

Thomas Story & Son LLC lessened its stake in Procter & Gamble Co (NYSE:PG) by 4.0% during the third quarter, HoldingsChannel reports. The firm owned 82,106 shares of the company’s stock after selling 3,399 shares during the period. Procter & Gamble comprises approximately 5.3% of Thomas Story & Son LLC’s portfolio, making the stock its 6th biggest holding. Thomas Story & Son LLC’s holdings in Procter & Gamble were worth $10,212,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Procter & Gamble by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 218,459,217 shares of the company’s stock valued at $23,954,054,000 after purchasing an additional 3,786,962 shares in the last quarter. BlackRock Inc. grew its position in shares of Procter & Gamble by 1.5% during the 2nd quarter. BlackRock Inc. now owns 167,930,647 shares of the company’s stock valued at $18,413,594,000 after purchasing an additional 2,470,382 shares in the last quarter. Phocas Financial Corp. grew its position in shares of Procter & Gamble by 999,937.0% during the 2nd quarter. Phocas Financial Corp. now owns 71,062,629 shares of the company’s stock valued at $77,920,000 after purchasing an additional 71,055,523 shares in the last quarter. Northern Trust Corp grew its position in shares of Procter & Gamble by 0.9% during the 2nd quarter. Northern Trust Corp now owns 33,064,470 shares of the company’s stock valued at $3,625,519,000 after purchasing an additional 295,521 shares in the last quarter. Finally, Nuveen Asset Management LLC grew its position in shares of Procter & Gamble by 6,899.0% during the 2nd quarter. Nuveen Asset Management LLC now owns 18,416,894 shares of the company’s stock valued at $2,019,412,000 after purchasing an additional 18,153,758 shares in the last quarter. 65.62% of the stock is currently owned by institutional investors.

In related news, CEO R. Alexandra Keith sold 62,930 shares of the business’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $119.98, for a total transaction of $7,550,341.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Vice Chairman Jon R. Moeller sold 141,575 shares of the business’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $118.05, for a total transaction of $16,712,928.75. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,645,966 shares of company stock valued at $202,229,770. Insiders own 1.75% of the company’s stock.

Shares of NYSE:PG traded up $0.08 during midday trading on Friday, hitting $119.70. 4,181,176 shares of the stock traded hands, compared to its average volume of 7,798,948. The stock has a market capitalization of $296.51 billion, a PE ratio of 26.48, a P/E/G ratio of 3.23 and a beta of 0.42. The business’s 50 day moving average is $121.95 and its two-hundred day moving average is $115.01. The company has a quick ratio of 0.54, a current ratio of 0.72 and a debt-to-equity ratio of 0.44. Procter & Gamble Co has a one year low of $86.74 and a one year high of $125.77.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Tuesday, October 22nd. The company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.24 by $0.13. The firm had revenue of $17.80 billion during the quarter, compared to the consensus estimate of $17.43 billion. Procter & Gamble had a net margin of 6.24% and a return on equity of 25.07%. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.12 earnings per share. As a group, sell-side analysts forecast that Procter & Gamble Co will post 4.93 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.7459 per share. This represents a $2.98 annualized dividend and a dividend yield of 2.49%. The ex-dividend date is Thursday, October 17th. Procter & Gamble’s dividend payout ratio (DPR) is 65.93%.

A number of research firms have recently commented on PG. ValuEngine lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. SunTrust Banks boosted their price target on shares of Procter & Gamble to $120.00 and gave the company a “hold” rating in a research report on Wednesday, July 31st. Morgan Stanley lifted their price objective on shares of Procter & Gamble from $130.00 to $134.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Goldman Sachs Group reaffirmed a “buy” rating and set a $136.00 price objective on shares of Procter & Gamble in a report on Wednesday, October 23rd. Finally, Stifel Nicolaus set a $117.00 price objective on shares of Procter & Gamble and gave the stock a “hold” rating in a report on Wednesday, July 31st. One analyst has rated the stock with a sell rating, nine have given a hold rating and ten have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $116.71.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Further Reading: Mutual Funds

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.